BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33022642)

  • 1. Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic Tumors.
    Maurichi A; Miceli R; Patuzzo R; Barretta F; Gallino G; Mattavelli I; Barbieri C; Leva A; Cortinovis U; Tolomio E; Sant M; Castelli G; Zichichi L; Pellacani G; Stanganelli I; Simonacci M; Manganoni A; Del Forno C; Caresana G; Harwood C; Bergamaschi D; Lasithiotakis K; Bennett D; Espeli V; Mangas C; Leoni Parvex S; Valeri B; Cossa M; Barisella M; Pellegrinelli A; Miranda C; Anichini A; Mortarini R; Zoras O; Santinami M
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1327-1336. PubMed ID: 33022642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
    Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
    J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy in thin and thick melanoma.
    Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
    Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma.
    Vucetić B; Andreja Rogan S; Balenović A; Ivkić M; Situm M; Hudorović N; Kusić Z
    Wien Klin Wochenschr; 2006 May; 118(9-10):286-93. PubMed ID: 16810487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
    Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
    Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in sentinel lymph node-positive pediatric melanoma.
    Roaten JB; Partrick DA; Bensard D; Pearlman N; Gonzalez R; Fitzpatrick J; McCarter MD
    J Pediatr Surg; 2005 Jun; 40(6):988-92; discussion 992. PubMed ID: 15991183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
    Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
    J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
    Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
    J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
    Tas F; Erturk K
    Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
    Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
    Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
    Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
    Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
    J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
    Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.